• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前蛋白转化酶枯草溶菌素9/低密度脂蛋白受体系统与类风湿关节炎相关动脉粥样硬化

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis.

作者信息

Arida Aikaterini, Legaki Aigli-Ioanna, Kravvariti Evrydiki, Protogerou Athanasios, Sfikakis Petros P, Chatzigeorgiou Antonios

机构信息

Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Front Cardiovasc Med. 2021 Oct 8;8:738764. doi: 10.3389/fcvm.2021.738764. eCollection 2021.

DOI:10.3389/fcvm.2021.738764
PMID:34692791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8531404/
Abstract

Rheumatoid arthritis (RA) is associated with the emergence of cardiovascular disease, while chronic inflammation is considered a common denominator for their parallel progression. The Proprotein convertase subtilisin/kexin type 9 (PCSK9)/LDL-Receptor (LDLR) system is of high importance during atherogenesis, via regulating the clearance of LDL from the circulation; nevertheless the role of this molecular mechanism during RA-related atheromatosis is not known. Herein, high-resolution ultrasound measurements for arterial hypertrophy, atheromatosis and arterial stiffness as well as comprehensive biochemical profiling were performed in 85 RA patients. The circulating levels of PCSK9 and LDLR were measured and their potential associations as well as of the PCSK9/LDLR ratio with patients' characteristics and the degree of atherosclerosis were investigated. Increased LDLR levels and decreased PCSK9/LDLR ratio were found in RA patients with at least 2 atheromatic plaques as compared to the ones without any plaques. In addition the levels of both PCSK9 and LDLR were positively correlated with the presence of atheromatic plaques as an age- and gender- adjusted multivariate analysis revealed. Our data imply that the PCSK9/LDLR system plays a significant role during RA-related atherosclerosis and may therefore be used as a screening tool for disease progression in the future.

摘要

类风湿性关节炎(RA)与心血管疾病的发生有关,而慢性炎症被认为是它们平行进展的共同因素。前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)/低密度脂蛋白受体(LDLR)系统在动脉粥样硬化形成过程中通过调节循环中低密度脂蛋白的清除起重要作用;然而,这种分子机制在RA相关动脉粥样硬化中的作用尚不清楚。在此,对85例RA患者进行了动脉肥厚、动脉粥样硬化和动脉僵硬度的高分辨率超声测量以及全面的生化分析。测量了PCSK9和LDLR的循环水平,并研究了它们之间的潜在关联以及PCSK9/LDLR比值与患者特征和动脉粥样硬化程度的关系。与无任何斑块的RA患者相比,至少有2个动脉粥样硬化斑块的RA患者LDLR水平升高,PCSK9/LDLR比值降低。此外,年龄和性别校正的多变量分析显示,PCSK9和LDLR水平均与动脉粥样硬化斑块的存在呈正相关。我们的数据表明,PCSK9/LDLR系统在RA相关动脉粥样硬化中起重要作用,因此未来可能用作疾病进展的筛查工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc6/8531404/183f9f0e3ceb/fcvm-08-738764-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc6/8531404/554415c3d263/fcvm-08-738764-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc6/8531404/183f9f0e3ceb/fcvm-08-738764-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc6/8531404/554415c3d263/fcvm-08-738764-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bc6/8531404/183f9f0e3ceb/fcvm-08-738764-g0002.jpg

相似文献

1
PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis.前蛋白转化酶枯草溶菌素9/低密度脂蛋白受体系统与类风湿关节炎相关动脉粥样硬化
Front Cardiovasc Med. 2021 Oct 8;8:738764. doi: 10.3389/fcvm.2021.738764. eCollection 2021.
2
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.衔接蛋白 1 是蛋白水解酶原转化酶枯草溶菌素/柯萨奇蛋白酶 9 的结合伴侣,并且对于蛋白水解酶原转化酶枯草溶菌素/柯萨奇蛋白酶 9 降解低密度脂蛋白受体是必需的。
Eur Heart J. 2020 Jan 7;41(2):239-252. doi: 10.1093/eurheartj/ehz566.
3
PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.在缺乏载脂蛋白E的情况下,前蛋白转化酶枯草溶菌素9(PCSK9)抑制作用无法改变肝脏低密度脂蛋白受体、循环胆固醇及动脉粥样硬化情况。
J Lipid Res. 2014 Nov;55(11):2370-9. doi: 10.1194/jlr.M053207. Epub 2014 Sep 25.
4
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.针对枯草溶菌素转化酶 9 治疗血脂异常和动脉粥样硬化。
J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21.
5
Proprotein Convertase Subtilisin/Kexin-Type 9 and Lipid Metabolism.丝氨酸蛋白酶原 9 与脂质代谢。
Adv Exp Med Biol. 2020;1276:137-156. doi: 10.1007/978-981-15-6082-8_9.
6
β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells.β-雌二醇导致人肝HuH7细胞中低密度脂蛋白受体水平在一种枯草杆菌蛋白酶/kexin 9型前蛋白转化酶依赖的情况下升高。
FEBS J. 2015 Jul;282(14):2682-96. doi: 10.1111/febs.13309. Epub 2015 May 18.
7
Proprotein convertase subtilisin/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1).前蛋白转化酶枯草溶菌素 9(PCSK9)可以介导低密度脂蛋白受体相关蛋白 1(LRP-1)的降解。
PLoS One. 2013 May 13;8(5):e64145. doi: 10.1371/journal.pone.0064145. Print 2013.
8
Structure and Function of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in Hyperlipidemia and Atherosclerosis.载脂蛋白代谢相关蛋白 9(PCSK9)在高脂血症和动脉粥样硬化中的结构与功能。
Curr Drug Targets. 2019;20(10):1029-1040. doi: 10.2174/1389450120666190214141626.
9
Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.血清脯氨酰肽链内切酶/克胰蛋白酶 9 和细胞表面低密度脂蛋白受体:相互调节的证据。
Circulation. 2013 Jun 18;127(24):2403-13. doi: 10.1161/CIRCULATIONAHA.113.001592. Epub 2013 May 20.
10
[The expression and clinical significance of proprotein convertase subtilisin kexin 9 in rheumatoid arthritis].[前蛋白转化酶枯草溶菌素9在类风湿关节炎中的表达及临床意义]
Zhonghua Nei Ke Za Zhi. 2017 Sep 1;56(9):655-659. doi: 10.3760/cma.j.issn.0578-1426.2017.09.007.

引用本文的文献

1
Increased PCSK9 associated with cIMT in AS: A useful marker for subclinical atherosclerosis in patients with ankylosing spondylitis.强直性脊柱炎患者中,前蛋白转化酶枯草溶菌素9(PCSK9)升高与动脉粥样硬化患者的颈动脉内膜中层厚度(cIMT)相关:一种用于亚临床动脉粥样硬化的有用标志物
Arch Rheumatol. 2024 Dec 12;39(4):652-661. doi: 10.46497/ArchRheumatol.2024.10625. eCollection 2024 Dec.
2
PCSK9 in T-cell function and the immune response.前蛋白转化酶枯草溶菌素9在T细胞功能和免疫反应中的作用
Biomark Res. 2024 Dec 31;12(1):163. doi: 10.1186/s40364-024-00712-8.
3
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.

本文引用的文献

1
Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms.低水平的前蛋白转化酶枯草溶菌素9(PCSK9)与接受抗肿瘤坏死因子-α(anti-TNF-α)治疗的类风湿关节炎患者的病情缓解相关:潜在的潜在机制。
Arthritis Res Ther. 2021 Jan 19;23(1):32. doi: 10.1186/s13075-020-02386-7.
2
Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data.甲氨蝶呤可降低银屑病患者中前致动脉粥样硬化血脂谱风险的新型指标——前蛋白转化酶枯草溶菌素9(PCSK9)的水平:初步数据
J Clin Med. 2020 Mar 26;9(4):910. doi: 10.3390/jcm9040910.
3
靶向前蛋白转化酶枯草溶菌素 9(PCSK9):从实验室到临床。
Signal Transduct Target Ther. 2024 Jan 8;9(1):13. doi: 10.1038/s41392-023-01690-3.
4
Dyslipidemia in rheumatoid arthritis: the possible mechanisms.类风湿关节炎中的血脂异常:可能的机制。
Front Immunol. 2023 Oct 25;14:1254753. doi: 10.3389/fimmu.2023.1254753. eCollection 2023.
5
Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren's Syndrome.探讨原发性干燥综合征患者血浆 PCSK9 水平、免疫失调与动脉粥样硬化的关系。
Biomolecules. 2023 Sep 12;13(9):1384. doi: 10.3390/biom13091384.
6
Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation.前蛋白转化酶枯草溶菌素9对动脉粥样硬化性心血管疾病的影响及其机制:聚焦免疫调节
Front Cardiovasc Med. 2023 Mar 10;10:1148486. doi: 10.3389/fcvm.2023.1148486. eCollection 2023.
7
PCSK9 inhibitor inclisiran for treating atherosclerosis via regulation of endothelial cell pyroptosis.前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂inclisiran通过调节内皮细胞焦亡治疗动脉粥样硬化。
Ann Transl Med. 2022 Nov;10(22):1205. doi: 10.21037/atm-22-4652.
8
Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren's Syndrome.类风湿关节炎和干燥综合征中乳脂肪球表皮生长因子8(MFGE8)基因变体
J Clin Med. 2022 Feb 23;11(5):1180. doi: 10.3390/jcm11051180.
The enigma of soluble LDLR: could inflammation be the key?
可溶性 LDLR 的谜团:炎症会是关键吗?
Lipids Health Dis. 2020 Feb 3;19(1):17. doi: 10.1186/s12944-020-1199-9.
4
PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1.PCSK9 与炎症:切应力、促炎细胞因子和 LOX-1 的作用。
Cardiovasc Res. 2020 Apr 1;116(5):908-915. doi: 10.1093/cvr/cvz313.
5
PCSK9 and inflammation: a review of experimental and clinical evidence.PCSK9 与炎症:实验与临床证据的综述。
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):237-245. doi: 10.1093/ehjcvp/pvz022.
6
Emerging role of proprotein convertase subtilisin/kexin type-9 (PCSK-9) in inflammation and diseases.PCSK-9 在炎症和疾病中的新兴作用。
Toxicol Appl Pharmacol. 2019 May 1;370:170-177. doi: 10.1016/j.taap.2019.03.018. Epub 2019 Mar 23.
7
Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients.白细胞介素-6受体阻断对类风湿关节炎患者前蛋白转化酶枯草杆菌蛋白酶/克新9型及胆固醇流出能力的影响
Horm Metab Res. 2019 Mar;51(3):200-209. doi: 10.1055/a-0833-4627. Epub 2019 Jan 29.
8
Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials.前蛋白转化酶枯草溶菌素9单克隆抗体对循环血中高敏C反应蛋白水平的影响:一项随机对照试验的系统评价和荟萃分析
BMJ Open. 2018 Oct 4;8(9):e022348. doi: 10.1136/bmjopen-2018-022348.
9
Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function.在一个白人队列中可溶性 LDLR 与脂蛋白之间的关联及 PCSK9 失活功能的影响。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3486-3495. doi: 10.1210/jc.2018-00777.
10
Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases.系统性炎症反应与动脉粥样硬化:慢性炎症性风湿性疾病的范例。
Int J Mol Sci. 2018 Jun 27;19(7):1890. doi: 10.3390/ijms19071890.